As of 2025-07-05, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (12.91) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.30 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -400.2%.
The range of the Relative Valuation is (9.88) - (17.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 18.7x | 13.1x |
| Forward P/E multiples | 10.3x - 21.3x | 13.7x |
| Fair Price | (9.88) - (17.97) | (12.91) |
| Upside | -329.8% - -518.0% | -400.2% |
| Date | P/E |
| 2025-07-03 | -4.46 |
| 2025-07-02 | -4.15 |
| 2025-07-01 | -4.08 |
| 2025-06-30 | -3.98 |
| 2025-06-27 | -3.93 |
| 2025-06-26 | -4.02 |
| 2025-06-25 | -3.64 |
| 2025-06-24 | -3.48 |
| 2025-06-23 | -3.20 |
| 2025-06-20 | -3.17 |
| 2025-06-18 | -3.29 |
| 2025-06-17 | -3.21 |
| 2025-06-16 | -3.14 |
| 2025-06-13 | -2.89 |
| 2025-06-12 | -3.04 |
| 2025-06-11 | -3.07 |
| 2025-06-10 | -2.79 |
| 2025-06-09 | -2.77 |
| 2025-06-06 | -2.76 |
| 2025-06-05 | -2.54 |
| 2025-06-04 | -2.56 |
| 2025-06-03 | -2.44 |
| 2025-06-02 | -2.20 |
| 2025-05-30 | -2.23 |
| 2025-05-29 | -2.37 |
| 2025-05-28 | -2.30 |
| 2025-05-27 | -2.28 |
| 2025-05-23 | -2.30 |
| 2025-05-22 | -2.34 |
| 2025-05-21 | -2.34 |
| 2025-05-20 | -2.45 |
| 2025-05-19 | -2.51 |
| 2025-05-16 | -2.24 |
| 2025-05-15 | -2.24 |
| 2025-05-14 | -2.25 |
| 2025-05-13 | -2.16 |
| 2025-05-12 | -2.29 |
| 2025-05-09 | -2.26 |
| 2025-05-08 | -2.24 |
| 2025-05-07 | -2.09 |
| 2025-05-06 | -2.18 |
| 2025-05-05 | -2.80 |
| 2025-05-02 | -2.92 |
| 2025-05-01 | -2.81 |
| 2025-04-30 | -2.75 |
| 2025-04-29 | -2.79 |
| 2025-04-28 | -2.87 |
| 2025-04-25 | -2.76 |
| 2025-04-24 | -2.75 |
| 2025-04-23 | -2.51 |